Kush Arvind
SEC CIK 1986806 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | Dir | 145.0K | $198.7K | — | 1 | 2024-10-21 | 2024-10-21 |
Most active insiders at IKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SANDS FRANK M. | 10% | $3.00M | — |
| 2 | Cabell Christopher | Pres, Head of R, D | — | — |
| 3 | Aurentz Vincent | Dir | — | — |
| 4 | Munshi Amit | Dir | — | — |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
| 6 | BERMAN DENNIS N | Dir | — | — |
Kush Arvind made no open-market trades at IKT in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-23 | 2024-10-21 | IKT | Inhibikase Therapeutics, Inc. | Kush Arvind | Dir | P - Purchase | $1.37 | +145.0K | 145.0K | New | +$198.7K |
Purchase Sale Sale after option exercise All abbreviations